Potent Antitubulin Tumor Cell Cytotoxins Based on 3-Aroyl Indazoles
Mark Matteucci(Threshold Pharmaceuticals (United States)), Xiaohong Cai(Wenzhou Medical University), Fanying Meng(Hunan University of Traditional Chinese Medicine), Charles P. Hart(University of Auckland), Lingyun Lan(University of Auckland)
Cited by 50
Related Papers
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
|Molecular Cancer Therapeutics|2011|206
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL
|Clinical Cancer Research|2019|53
Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer
|Cancer Biology & Therapy|2015|51